About Michael Liang
Form D filings for Zurex Pharma from 2014 to 2020 list Michael Liang as director.
Michael Liang first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Liang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Liang works with at each company, as listed on that company's latest Form D.
Zurex Pharma, Inc. · Form D, Jun 16, 2020
FR
Frederick Robertson
Director
CD
Carmine Durham
Chief Executive Officer and director
AK
Alexander Kasper
Executive officer
RM
Roy Morgan
Executive officer
RT
Robert Truitt
Director